These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28381719)

  • 1. [Practice of Regulatory Science (Drug Development)].
    Kawanishi T
    Yakugaku Zasshi; 2017; 137(4):427-430. PubMed ID: 28381719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Greeting and General Statement by the Organizer].
    Shiragami M
    Yakugaku Zasshi; 2017; 137(4):423-426. PubMed ID: 28381718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulatory Science in Professional Education].
    Akiyama H
    Yakugaku Zasshi; 2017; 137(4):447-452. PubMed ID: 28381723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current Status of Regulatory Science Education in Faculties of Pharmaceutical Science in Japan].
    Tohkin M
    Yakugaku Zasshi; 2017; 137(4):453-457. PubMed ID: 28381724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Report: Promotion of Social Contributions of Research on Clinical Pharmacy and Pharmaceutical Sciences].
    Mochizuki M
    Yakugaku Zasshi; 2019; 139(3):393-394. PubMed ID: 30828016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Role of the Pharmaceutical Society of Japan in Advancing of Clinical Pharmacy Research].
    Oku N
    Yakugaku Zasshi; 2019; 139(3):401-404. PubMed ID: 30828018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The principle of safety evaluation in medicinal drug - how can toxicology contribute to drug discovery and development as a multidisciplinary science?
    Horii I
    J Toxicol Sci; 2016; 41(Special):SP49-SP67. PubMed ID: 28250284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Basis for Pharmaceutical Sciences "Quality Assurance": Quality Assurance of Health Foods, Foods with Health Claims, and Pharmaceutics].
    Goda Y
    Yakugaku Zasshi; 2021; 141(6):787-791. PubMed ID: 34078783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective.
    Tucker G; DeSilva B; Dressman J; Ito M; Kumamoto T; Mager D; Mahler HC; Maitland-van der Zee AH; Pauletti GM; Sasaki H; Shah V; Tang D; Ward M
    J Pharm Sci; 2016 Sep; 105(9):2489-2497. PubMed ID: 26886325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulatory Science in Practice (Pharmaceuticals and Medical Devices Agency)].
    Hojo T
    Yakugaku Zasshi; 2017; 137(4):439-442. PubMed ID: 28381721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Summary of a Report from the Science Council of Japan].
    Takakura Y
    Yakugaku Zasshi; 2019; 139(3):395-400. PubMed ID: 30828017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulatory science: modern trends in science and education for pharmaceutical products].
    Beregovykh VV; Piatigorskaia NV; Aladysheva ZhI
    Vestn Ross Akad Med Nauk; 2012; (12):41-6. PubMed ID: 23530425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical science research training: an early practice course for first-year students.
    Wu HS; Zhu KL; Fan XH; Gao JQ
    Med Educ; 2018 Nov; 52(11):1200-1201. PubMed ID: 30255514
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical-pharmacological aspects to accelerate the development process from the preclinical to the clinical phase/1st communication: The contribution of clinical pharmacology].
    Kuhlmann J
    Arzneimittelforschung; 2004; 54(5):251-8. PubMed ID: 15212186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality Assurance in Toxicology and Safety Science].
    Tsutsumi Y
    Yakugaku Zasshi; 2021; 141(6):813-816. PubMed ID: 34078786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaceutical product quality control and good manufacturing practices].
    Hiyama Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Container-content compatibility studies: a pharmaceutical team's integrated approach.
    Laschi A; Sehnal N; Alarcon A; Barcelo B; Caire-Maurisier F; Delaire M; Feuilloley M; Genot S; Lacaze C; Pisarik L; Smati C
    PDA J Pharm Sci Technol; 2009; 63(4):285-93. PubMed ID: 20088243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Introduction of outcome-based education in pharmaceutical education in Japan].
    Takahashi H; Kosano H
    Yakugaku Zasshi; 2015; 135(3):339-43. PubMed ID: 25759038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.